Medicare Enrolled

Dr. Gowtham Jonna, M.D.

Retina Specialist (Ophthalmology) Physician · Austin, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
3705 MEDICAL PKWY STE 460, Austin, TX 78705
5124545851
Registered in NPPES since 2011
NPI: 1245529767 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jonna from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jonna? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jonna

Dr. Gowtham Jonna is a retina specialist physician in Austin, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Jonna performed 7,453 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Jonna received a total of $6,137 from 23 pharmaceutical and/or device companies across 69 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jonna is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years of NPI registration ▲ Top 48% volume in TX $6,137 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
7,453
Medicare services
Top 48% in TX for retina specialist (ophthalmology) physician
Not available
Unique patients (not deduplicated)
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
4,260 $29 $110
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
847 $29 $90
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
631 $18 $66
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
427 $86 $173
Aflibercept eye injection (Eylea) 354 $693 $2,000
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
335 $94 $300
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
159 $67 $115
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
112 $131 $220
New patient office visit, complex (60-74 min) 80 $155 $309
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
73 $57 $260
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
55 $27 $156
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
55 $90 $157
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
29 $94 $252
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
24 $112 $263
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
12 $8 $66
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,137
Total received (2018-2024)
Avg $877/year across 7 years
Top 36% in TX for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
69
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$188
2023
$388
2022
$1,034
2021
$585
2020
$128
2019
$2,950
2018
$864

Payments by company (2024)

Regeneron Healthcare Solutions, Inc.
$102
Genentech USA, Inc.
$58
Astellas Pharma US Inc
$28
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,220
Novartis Pharmaceuticals Corporation
$482
Genentech USA, Inc.
$356
TissueTech, Inc.
$304
Regeneron Pharmaceuticals, Inc.
$263
Allergan Inc.
$249
Genentech, Inc.
$234
EyePoint Pharmaceuticals US, Inc.
$200
ABBVIE INC.
$199
Johnson & Johnson Surgical Vision, Inc.
$195
Heidelberg Engineering, Inc.
$184
Regeneron Healthcare Solutions, Inc.
$174
BioTissue Holdings, Inc.
$146
Allergan, Inc.
$138
Merz North America, Inc.
$136
Ocular Therapeutix, Inc.
$124
Horizon Therapeutics plc
$124
Alimera Sciences, Inc.
$116
Spark Therapeutics, Inc.
$110
Dutch Ophthalmic, USA
$80
Biogen, Inc.
$44
Apellis Pharmaceuticals, Inc.
$30
Astellas Pharma US Inc
$28
Top 3 companies account for 49.8% of all-time payments
Associated products mentioned in payments ›
BEOVU · BROLUCIZUMAB · DEXTENZA · DURYSTA · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Iluvien · Izervay · LUXTURNA · Lucentis · OZURDEX · One Series Ultra · PROKERA · Prokera · Spectralis · Syfovre · TEPEZZA · Tecnis IOL · VABYSMO · VUITY · Vabysmo · XEOMIN · YUTIQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a retina specialist physician in Austin?
Compare retina specialist physicians in the Austin area by procedure volume, costs, and industry payment transparency.
Browse retina specialist physicians nearby

Geographic Context

Retina specialist physicians in nearby ZIP areas
6
County median income
$97,169
Nearest hospital to ZIP centroid (approximate)
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Jonna is a mixed practice specialist, with moderate Medicare volume, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Jonna experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Jonna performed 4,260 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Jonna receive payments from pharmaceutical companies?
Yes. Dr. Jonna received a total of $6,137 from 23 companies across 69 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jonna's costs compare to other retina specialist physicians in Austin?
Dr. Jonna's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jonna) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →